Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 1994

Primary Completion Date

January 31, 1996

Study Completion Date

January 31, 1996

Conditions
Opioid-Related DisordersSubstance-Related Disorders
Interventions
DRUG

30% N2O

DRUG

0.2% isoflurane

DRUG

0.4% isoflurane

OTHER

100% oxygen

Placebo

Trial Locations (1)

60637

University of Chicago, Anesthesia & Critical Care, Chicago

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Chicago

OTHER